메뉴 건너뛰기




Volumn 16, Issue 1, 2016, Pages

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer

(16)  She, Qing Bai a,b   Gruvberger Saal, Sofia K c,d   Maurer, Matthew e   Chen, Yilun c   Jumppanen, Mervi f   Su, Tao e   Dendy, Meaghan d   Lau, Ying Ka Ingar e   Memeo, Lorenzo g   Horlings, Hugo M h   van de Vijver, Marc J i   Isola, Jorma j   Hibshoosh, Hanina e   Rosen, Neal a   Parsons, Ramon d,e,k   Saal, Lao H c,d  


Author keywords

Basal like; Breast cancer; Combination therapy; EGFR; PTEN

Indexed keywords

17 HYDROXYWORTMANNIN; 2 MORPHOLINO 8 PHENYLCHROMONE; CYTOKERATIN 14; CYTOKERATIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GEFITINIB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STATHMIN; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; EGFR PROTEIN, HUMAN; MACROGOL DERIVATIVE; MORPHOLINE DERIVATIVE; PEGYLATED 17-HYDROXYWORTMANNIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHATIDYLINOSITOL-3,4-BISPHOSPHATE 4-PHOSPHATASE; PIK3CA PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; PTEN PROTEIN, HUMAN; QUINAZOLINE DERIVATIVE;

EID: 84980343511     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2609-2     Document Type: Article
Times cited : (25)

References (56)
  • 1
    • 67049119497 scopus 로고    scopus 로고
    • Basal-like breast carcinoma: from expression profiling to routine practice
    • Rakha E, Reis-Filho JS. Basal-like breast carcinoma: from expression profiling to routine practice. Arch Pathol Lab Med. 2009;133(6):860-8.
    • (2009) Arch Pathol Lab Med , vol.133 , Issue.6 , pp. 860-868
    • Rakha, E.1    Reis-Filho, J.S.2
  • 2
    • 20144387695 scopus 로고    scopus 로고
    • PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
    • Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmstrom PO, Mansukhani M, Enoksson J, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005;65(7):2554-9.
    • (2005) Cancer Res , vol.65 , Issue.7 , pp. 2554-2559
    • Saal, L.H.1    Holm, K.2    Maurer, M.3    Memeo, L.4    Su, T.5    Wang, X.6    Yu, J.S.7    Malmstrom, P.O.8    Mansukhani, M.9    Enoksson, J.10
  • 3
    • 33645224005 scopus 로고    scopus 로고
    • PIK3CA mutations in breast cancer are associated with poor outcome
    • Li SY, Rong M, Grieu F, Iacopetta B. PIK3CA mutations in breast cancer are associated with poor outcome. Breast Cancer Res Treat. 2006;96(1):91-5.
    • (2006) Breast Cancer Res Treat , vol.96 , Issue.1 , pp. 91-95
    • Li, S.Y.1    Rong, M.2    Grieu, F.3    Iacopetta, B.4
  • 6
    • 84877028141 scopus 로고    scopus 로고
    • Comprehensive molecular portraits of human breast tumours
    • The Cancer Genome Atlas. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.
    • (2012) Nature , vol.490 , Issue.7418 , pp. 61-70
  • 12
    • 0025316902 scopus 로고
    • Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation
    • Bjorge JD, Chan TO, Antczak M, Kung HJ, Fujita DJ. Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. Proc Natl Acad Sci U S A. 1990;87(10):3816-20.
    • (1990) Proc Natl Acad Sci U S A , vol.87 , Issue.10 , pp. 3816-3820
    • Bjorge, J.D.1    Chan, T.O.2    Antczak, M.3    Kung, H.J.4    Fujita, D.J.5
  • 13
    • 0026780327 scopus 로고
    • Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation
    • Peles E, Lamprecht R, Ben-Levy R, Tzahar E, Yarden Y. Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation. J Biol Chem. 1992;267(17):12266-74.
    • (1992) J Biol Chem , vol.267 , Issue.17 , pp. 12266-12274
    • Peles, E.1    Lamprecht, R.2    Ben-Levy, R.3    Tzahar, E.4    Yarden, Y.5
  • 14
    • 82555185376 scopus 로고    scopus 로고
    • The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
    • Eccles SA. The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology. Int J Dev Biol. 2011;55(7-9):685-96.
    • (2011) Int J Dev Biol , vol.55 , Issue.7-9 , pp. 685-696
    • Eccles, S.A.1
  • 15
    • 5144226211 scopus 로고    scopus 로고
    • PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
    • Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, et al. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell. 2004;6(2):117-27.
    • (2004) Cancer Cell , vol.6 , Issue.2 , pp. 117-127
    • Nagata, Y.1    Lan, K.H.2    Zhou, X.3    Tan, M.4    Esteva, F.J.5    Sahin, A.A.6    Klos, K.S.7    Li, P.8    Monia, B.P.9    Nguyen, N.T.10
  • 18
    • 26644449670 scopus 로고    scopus 로고
    • The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
    • She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell. 2005;8(4):287-97.
    • (2005) Cancer Cell , vol.8 , Issue.4 , pp. 287-297
    • She, Q.B.1    Solit, D.B.2    Ye, Q.3    O'Reilly, K.E.4    Lobo, J.5    Rosen, N.6
  • 20
    • 0141960451 scopus 로고    scopus 로고
    • Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling
    • She QB, Solit D, Basso A, Moasser MM. Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. Clin Cancer Res. 2003;9(12):4340-6.
    • (2003) Clin Cancer Res , vol.9 , Issue.12 , pp. 4340-4346
    • She, Q.B.1    Solit, D.2    Basso, A.3    Moasser, M.M.4
  • 22
    • 53049092584 scopus 로고    scopus 로고
    • Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification
    • Nuyten DS, Hastie T, Chi JT, Chang HY, van de Vijver MJ. Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification. Eur J Cancer. 2008;44(15):2319-29.
    • (2008) Eur J Cancer , vol.44 , Issue.15 , pp. 2319-2329
    • Nuyten, D.S.1    Hastie, T.2    Chi, J.T.3    Chang, H.Y.4    Vijver, M.J.5
  • 24
    • 25144516817 scopus 로고    scopus 로고
    • Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
    • Laakso M, Loman N, Borg A, Isola J. Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol. 2005;18(10):1321-8.
    • (2005) Mod Pathol , vol.18 , Issue.10 , pp. 1321-1328
    • Laakso, M.1    Loman, N.2    Borg, A.3    Isola, J.4
  • 26
    • 0033694650 scopus 로고    scopus 로고
    • Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples
    • Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J. Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol. 2000;157(5):1467-72.
    • (2000) Am J Pathol , vol.157 , Issue.5 , pp. 1467-1472
    • Tanner, M.1    Gancberg, D.2    Leo, A.3    Larsimont, D.4    Rouas, G.5    Piccart, M.J.6    Isola, J.7
  • 29
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
    • Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27-55.
    • (1984) Adv Enzyme Regul , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2
  • 32
    • 9444225935 scopus 로고    scopus 로고
    • Java Treeview--extensible visualization of microarray data
    • Saldanha AJ. Java Treeview--extensible visualization of microarray data. Bioinformatics. 2004;20(17):3246-8.
    • (2004) Bioinformatics , vol.20 , Issue.17 , pp. 3246-3248
    • Saldanha, A.J.1
  • 33
    • 0037221767 scopus 로고    scopus 로고
    • TP53 and breast cancer
    • Borresen-Dale AL. TP53 and breast cancer. Hum Mutat. 2003;21(3):292-300.
    • (2003) Hum Mutat , vol.21 , Issue.3 , pp. 292-300
    • Borresen-Dale, A.L.1
  • 38
    • 0034920457 scopus 로고    scopus 로고
    • Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer
    • Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol. 2001;14(7):672-6.
    • (2001) Mod Pathol , vol.14 , Issue.7 , pp. 672-676
    • Depowski, P.L.1    Rosenthal, S.I.2    Ross, J.S.3
  • 44
    • 23644451118 scopus 로고    scopus 로고
    • PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors
    • Yu K, Lucas J, Zhu T, Zask A, Gaydos C, Toral-Barza L, Gu J, Li F, Chaudhary I, Cai P, et al. PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors. Cancer Biol Ther. 2005;4(5):538-45.
    • (2005) Cancer Biol Ther , vol.4 , Issue.5 , pp. 538-545
    • Yu, K.1    Lucas, J.2    Zhu, T.3    Zask, A.4    Gaydos, C.5    Toral-Barza, L.6    Gu, J.7    Li, F.8    Chaudhary, I.9    Cai, P.10
  • 45
    • 0031107250 scopus 로고    scopus 로고
    • The epidermal growth factor receptor in breast cancer
    • Fox SB, Harris AL. The epidermal growth factor receptor in breast cancer. J Mammary Gland Biol Neoplasia. 1997;2(2):131-41.
    • (1997) J Mammary Gland Biol Neoplasia , vol.2 , Issue.2 , pp. 131-141
    • Fox, S.B.1    Harris, A.L.2
  • 46
    • 33846160505 scopus 로고    scopus 로고
    • Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA
    • Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T. Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA. Mol Cell Biol. 2007;27(2):662-77.
    • (2007) Mol Cell Biol , vol.27 , Issue.2 , pp. 662-677
    • Kim, J.S.1    Lee, C.2    Bonifant, C.L.3    Ressom, H.4    Waldman, T.5
  • 48
    • 32044435126 scopus 로고    scopus 로고
    • Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways
    • Levine AJ, Feng Z, Mak TW, You H, Jin S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 2006;20(3):267-75.
    • (2006) Genes Dev , vol.20 , Issue.3 , pp. 267-275
    • Levine, A.J.1    Feng, Z.2    Mak, T.W.3    You, H.4    Jin, S.5
  • 50
    • 69349093749 scopus 로고    scopus 로고
    • Phosphoinositide 3-kinase mutations in breast cancer: a "good" activating mutation?
    • Di Cosimo S, Baselga J. Phosphoinositide 3-kinase mutations in breast cancer: a "good" activating mutation? Clin Cancer Res. 2009;15(16):5017-9.
    • (2009) Clin Cancer Res , vol.15 , Issue.16 , pp. 5017-5019
    • Cosimo, S.1    Baselga, J.2
  • 52
    • 0035971181 scopus 로고    scopus 로고
    • Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance
    • Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem. 2001;276(13):9817-24.
    • (2001) J Biol Chem , vol.276 , Issue.13 , pp. 9817-9824
    • Campbell, R.A.1    Bhat-Nakshatri, P.2    Patel, N.M.3    Constantinidou, D.4    Ali, S.5    Nakshatri, H.6
  • 53
    • 0036633164 scopus 로고    scopus 로고
    • Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells
    • Clark AS, West K, Streicher S, Dennis PA. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther. 2002;1(9):707-17.
    • (2002) Mol Cancer Ther , vol.1 , Issue.9 , pp. 707-717
    • Clark, A.S.1    West, K.2    Streicher, S.3    Dennis, P.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.